A Homeopathic View of the Influence of Chronic Diseases in the Manifestation of COVID-19

Abstract

COVID-19 (coronavirus disease 2019) may present variable symptoms among infected individuals, with chronic disease patients appearing as the group most susceptible to present severe pulmonary infection, while having a higher risk of developing complications from the disease. This study demonstrates the relationship between the manifestation of COVID-19 and the presence of chronic miasmatic disease, based on the works of Samuel Hahnemann. The reaction of the individual who previously presented chronic miasmatic disease, when in contact with the stimulus of the epidemic disease, depends on the type of response that the organism was generating in the face of the pre-existing situation: if it is an intense reaction and greater than that which the stimulus of COVID-19 can generate, this individual will not develop the severe form of the epidemic disease; if the reaction is less than that generated by COVID-19, more intense symptoms may appear. Understanding that the presence of a chronic miasmatic disease interferes with the manifestation of COVID-19, which may have repercussions on other organs, can change how one must act on the treatment, as this can alter the individual's health status.

Keywords

COVID-19 - homeopathy - chronic disease

• References

• 1 Gorbalenya AE, Baker SC, Baric RS. and the Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020; 5: 536-544
• 2 Brasil. Ministério da Saúde, Protocolo de Manejo Clínico da Covid-19 na Atenção Especializada, Brasília. 2020 . Accessed April 10, 2020 at: https://portalarquivos.saude.gov.br/images/pdf/2020/April/07/20200407-ProtocoloManejo-ver07.pdf
• 3 Centers for Disease Control and Prevention.. Infection Control Guidance for Healthcare Professionals about Coronavirus (COVID-19). Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html. June 3, 2020
• 4 Patel AB, Verma A. COVID-19 and angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what is the evidence?. JAMA 2020; 323: 1769-1770
• 5 Rezende LFM, Thome B, Schveitzer MC, Souza-Júnior PRB, Szwarcwald CL. Adultos com alto risco de doença grave por coronavírus-2019 (Covid-19) no Brasil. Rev Saude Publica 2020; 54: 50
• 6 Hahnemann S. Doenças crônicas—sua natureza peculiar e sua cura homeopática. 8th ed. São Paulo: Grupo de Estudos Homeopáticos de São Paulo (GEHSP) “Benoit Mure”; 2020
• 7 Hahnemann S. Exposição da doutrina homeopática ou Organon da arte de curar. 7th ed. São Paulo: Grupo de Estudos Homeopáticos de São Paulo (GEHSP) “Benoit Mure”; 2019
• 8 Hahnemann S. Doenças crônicas—sua natureza peculiar e sua cura homeopática. 8th ed. São Paulo: Grupo de Estudos Homeopáticos de São Paulo (GEHSP) “Benoit Mure”; 2020: 77
• 9 Hahnemann S. Exposição da doutrina homeopática ou Organon da arte de curar. 7th ed. São Paulo: Grupo de Estudos Homeopáticos de São Paulo (GEHSP) “Benoit Mure”; 2019: 11-19
• 10 Hahnemann S. Exposição da doutrina homeopática ou Organon da arte de curar. 7th ed. São Paulo: Grupo de Estudos Homeopáticos de São Paulo (GEHSP) “Benoit Mure”; 2019: 35-40